| 1Azithromycin Impurity L |
|---|
| 2Azithromycin Impurity C |
| 3Azithromycin Impurity M |
| 4Azithromycin Impurity E |
| 5Azithromycin Impurity F |
| 6Azithromycin Impurity J |
| 7Azithromycin Impurity I |
| 8Azithromycin Impurity N |
| 9Azithromycin Impurity A |
| 10Azithromycin Impurity P |
| 11Azithromycin |
| 12Azithromycin Impurity O |
| 13Azithromycin Impurity G |
| 14Azithromycin Impurity B |
search
Applications
Ph. Eur. Azithromycin - Related Substances peak identification solution injection on Gemini™ 3 µm NX-C18 150 x 4.6 mm using Waters® Arc HPLC system
27302
Separation Mode: Reversed Phase
Reversed Phase
Ph.Eur. M.1649
NX-C18
HPLC
Anti-Bacterial Agents
Pharmaceutical
Pharmaceutical
Therapeutic / Clinical
Ph. Eur. Azithromycin - Related Substances peak identification solution injection on Gemini™ 3 µm NX-C18 150 x 4.6 mm using Waters® Arc HPLC system
Analytes
Details
Official Method: Ph.Eur. M.1649
LC Conditions (App ID: 27302)
Column: |
Brand Name: Gemini |
Part No: |
Phase Name: NX-C18 |
System: Waters Arc HPLC Waters Arc HPLC |
Sample Note: Diluent buffer: 1.73 g/L solution of ammonium dihydrogen pH adjusted to 10.0 with ammonia
Diluent: Diluent buffer: Acetonitrile: methanol = 35:30:35 (v/v/v) |
Similar Applications
search
No Data
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide